Compositions of N- [2,4-bis(1,1-dimethylethyl)-5-hydroxyph enyl)-1,4-dihydro-4-oxoquinoline-3-carb oxamide

Details for Australian Patent Application No. 2007249269 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Rowe, Charles William; Young, Christopher R.

Agent Cullen & Co

Pub. Number AU-A-2007249269

PCT Pub. Number WO2007/134279

Priority 60/799,795 12.05.06 US

Filing date 14 May 2007

Wipo publication date 22 November 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/134279 Priority application(s): WO2007/134279

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007249270-Extruded filament for microscopic tagging system

2007249268-Systems and methods for data storage and retrieval